The loss of CREBBP in the Rb1/Trp53 GEMM (mainly belonging to the ASCL1 subtype) drastically contributed to the progression of SCLC, which can show an exceptional response to the histone deacetylase (HDAC) inhibitor pracinostat [71]. This evidence concerns the gene HDAC9 and small cell lung carcinoma.